Meningitis B Vaccine (2026)

A Contract Award Notice
by SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY

Source: Find a Tender
Type: Contract ()
Duration: not specified
Value: £1

Sector: MISCELLANEOUS
Published: 30 Jun 2026
Delivery: not specified
Deadline: n/a

Related Terms

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

Secretary of State for Health & Social Care Acting as Part of the Crown Through UK Health Security Agency London

1 supplier

Glaxosmithkline London

Description

The provision of a vaccine to protect against meningococcal B (MenB) disease, to be used in the national childhood immunisation programme, as well as a targeted programme to protect at risk adults against Gonorrhoea. Value - The contract value is withheld from publication pursuant to regulation 94(2)(b) of the Procurement Act 2023, so as not to prejudice the legitimate commercial interest of the supplier.

Award Detail

1	Glaxosmithkline (London) Meningitis B Vaccine (2026) Reference: 2 Value: £1

CPV Codes

None found

Legal Justification

The following conditions are met in relation to the public contract under Schedule 5, Paragraph 5 (a, b) of the Procurement Act 2023- (a) due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods, services or works.